Add BrightSurf on Google Email

HIV vaccine in worldwide trial

Vanderbilt University is one of nine US sites participating in a phase I trial of the Merck HIV vaccine, designed to test its safety and ability to stimulate immune responses in healthy volunteers. The study aims to generate cellular immune responses that could prevent the virus from spreading in the body.

Dietary supplement and flu vaccines

A recent study published in the Canadian Medical Association Journal investigated the effects of a Chlorella-derived dietary supplement on immune function and influenza vaccination. The results showed no significant increase in antibody response to the flu vaccine overall, although some increase was seen in participants aged 50 to 55.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·DateJul 21, 2003

Turning foe into friend with lentiviral vectors

Researchers have developed a third-generation lentivector that transduces dendritic cells in vivo, inducing a strong and persistent antigen-specific immune response. This approach may replace costly and labor-intensive methods currently used to elicit tumor-specific cytotoxic T lymphocyte responses.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 2, 2003

Immune responses to peanuts are key in a growing allergic phenomenon

A study published in JCI Journals identified unique immunological factors produced by immune cells of peanut-allergic children compared to non-allergic individuals and those who outgrown their allergies. These findings suggest the development of allergic reactions depends on host immune response rather than inherent allergenic properties.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 1, 2003

Pheromone receptors need 'escorts'

Researchers discovered that MHC proteins, including M10, play a crucial role in detecting and modulating pheromone activity in mice. The findings suggest that these proteins may act as escorts for pheromone receptors, allowing them to reach the surface of neurons where chemical reception takes place.

Colorado State microbiologists help identify cell membrane substance that could 'boost' vaccines for tuberculosis, other diseases

Researchers have identified a substance produced by the tuberculosis bacterium that triggers an immune response, suggesting it could enhance vaccine effectiveness. The substance, combined with vaccines, may push the body's immune system in the right direction to fight tuberculosis and other microbial infections.

SourceColorado State University·JournalScience·DateJul 30, 1999